Amgen

The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Mirati CEO Steps Down After Going Toe-to-Toe with Amgen in KRAS
BioSpace
Wed, 08/9/23 - 11:55 am
Mirati Therapeutics
Pharma CEOs
David Meek
Amgen
KRAS inhibitors
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Fri, 08/4/23 - 12:30 pm
Amgen
oncology
colorectal cancer
small cell lung cancer
tarlatamab
Lumakras
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Fierce Pharma
Fri, 08/4/23 - 11:56 am
Amgen
AbbVie
biosimilars
Humira
Amgen's tarlatamab BiTEs at small cell lung cancer in brief readout
Fierce Biotech
Thu, 08/3/23 - 06:37 pm
Amgen
tarlatamab
small cell lung cancer
T-cells
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
AbbVie
Skyrizi
Amgen
Otezla
Boehringer Ingelheim
psoriasis
Amgen’s lupus bets continue to flounder, even those on the Horizon
Fierce Biotech
Mon, 07/24/23 - 10:24 am
Horizon Therapeutics
Amgen
lupus
daxdilimab
clinical trials
FTC, Amgen Break Off Settlement Talks Over Horizon Deal
BioSpace
Thu, 07/20/23 - 10:07 am
Amgen
Horizon Therapeutics
M&A
FTC
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
M&A
Amgen
Astellas
Eli Lilly
GSK
Horizon Therapeutics
Merck
Novartis
Pfizer
Seagen
States Back FTC in Lawsuit Seeking to Block Amgen-Horizon Deal
BioSpace
Fri, 06/23/23 - 09:53 am
Amgen
Horizon Therapeutics
M&A
FTC
Amgen granted full FDA approval for blood cancer treatment
Biopharma Reporter
Thu, 06/22/23 - 10:10 am
Amgen
Blincyto
FDA
blood cancer
Full circle for Paul Burton as Moderna exec returns to Amgen, this time for expanded CMO role
Fierce Biotech
Wed, 06/14/23 - 06:33 pm
Amgen
Moderna Therapeutics
Paul Burton
chief medical officers
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Medicare
Inflation Reduction Act
drug pricing
Amgen
Sanofi
Seagen
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Wed, 06/7/23 - 11:15 am
Amgen
Horizon Therapeutics
FTC
M&A
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Mon, 06/5/23 - 10:21 am
Amgen
Horizon Therapeutics
FTC
M&A
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wed, 05/24/23 - 11:18 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A

Pages